drugset / Trial / NCT00002181

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

NCT00002181

Completed Gilead Sciences
Open-labelTreatment

Summary

The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject CIDOFOVIR ANHYDROUS Small molecule